Anna Cederbalk is a Senior Scientist I at Evotec since September 2022, previously serving as a Senior Scientist at MoA Technology from November 2020 to September 2022, where responsibilities included managing technical execution for herbicidal discovery projects and overseeing synthetic chemistry progress through external collaborations. Prior experience includes a postdoctoral research position at the University of Oxford from August 2017 to November 2020, leading a structure-based drug design optimization program focused on Alzheimer’s research and developing compounds for Parkinson's target validation. Anna Cederbalk holds a Ph.D. in Medicinal and Pharmaceutical Chemistry from Københavns Universitet - University of Copenhagen and Master's degrees in Organic Chemistry from Lund University and Queen's University.
This person is not in any teams
This person is not in any offices